Tumor-induced osteomalacia (TIO) is an ultrarare paraneoplastic syndrome caused by overproduction of fibroblast growth factor 23 (FGF23). There is low awareness of the disease so that TIO is underdiagnosed. In addition, symptoms reported by patients with TIO are usually nonspecific thus rendering the diagnosis difficult to be made. Biochemical hallmarks are represented by hypophosphatemia, increased or inappropriately normal levels of FGF23, low to low normal circulating 1,25(OH)2D and renal phosphate wasting. From the histological point of view, phosphaturic mesenchymal tumors are the entities responsible in majority of cases. Tumors causing TIO are generally of small size and grow slowly. There are a number of functional and anatomical imaging techniques utilized for tumor localization; 68Ga DOTA based technologies have the better sensitivity and specificity in respect to other techniques. Surgery is the treatment of choice; in a very few selected cases non pharmacological and pharmacological treatment are available.

Tumor-induced osteomalacia: a 2026 update / Minisola, S., Fukumoto, S., Corsi, A., Colangelo, L., Riminucci, M., Scillitani, A., Pepe, J., Cipriani, C.. - In: MINERVA MEDICA. - ISSN 0026-4806. - 117:4(2026). [10.23736/s0026-4806.26.09744-2]

Tumor-induced osteomalacia: a 2026 update

MINISOLA, Salvatore;CORSI, Alessandro;COLANGELO, Luciano;RIMINUCCI, Mara;PEPE, Jessica;CIPRIANI, Cristiana
2026

Abstract

Tumor-induced osteomalacia (TIO) is an ultrarare paraneoplastic syndrome caused by overproduction of fibroblast growth factor 23 (FGF23). There is low awareness of the disease so that TIO is underdiagnosed. In addition, symptoms reported by patients with TIO are usually nonspecific thus rendering the diagnosis difficult to be made. Biochemical hallmarks are represented by hypophosphatemia, increased or inappropriately normal levels of FGF23, low to low normal circulating 1,25(OH)2D and renal phosphate wasting. From the histological point of view, phosphaturic mesenchymal tumors are the entities responsible in majority of cases. Tumors causing TIO are generally of small size and grow slowly. There are a number of functional and anatomical imaging techniques utilized for tumor localization; 68Ga DOTA based technologies have the better sensitivity and specificity in respect to other techniques. Surgery is the treatment of choice; in a very few selected cases non pharmacological and pharmacological treatment are available.
2026
Fibroblast growth factors; Phosphates; Osteomalacia; Bone fractures; Burosumab.
01 Pubblicazione su rivista::01a Articolo in rivista
Tumor-induced osteomalacia: a 2026 update / Minisola, S., Fukumoto, S., Corsi, A., Colangelo, L., Riminucci, M., Scillitani, A., Pepe, J., Cipriani, C.. - In: MINERVA MEDICA. - ISSN 0026-4806. - 117:4(2026). [10.23736/s0026-4806.26.09744-2]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1777366
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact